Work

Long‐COVID and long‐term cancer survivorship—Shared lessons and opportunities

Year: 2022

Type: article

Abstract: As of 2022, close to 90 million persons in the United States, 243 million persons in Europe and 585 million worldwide have been infected with the novel SARS-CoV-2 (COVID-19) virus and survived. Estimates vary but suggest that up to 50% may experience long-term sequelae, termed 'Long-COVID'. While Long-COVID is a new condition, the phenomenon of disabling long-term effects following an illness requiring ongoing surveillance and management is not. In this commentary, we discuss how Long-COVID parallels the experiences of long-term cancer survivors, highlight shared challenges and offer opportunities to improve research and clinical care for both growing populations of patients as well as other long-term chronic, disabling conditions.

Source: European Journal of Cancer Care

DOI: 10.1111/ecc.13712

Authors: Taku Harada, Kathryn Schmitz, Charles W. Helsper, Grace Campbell, Larissa Nekhlyudov

Institutions: University of Pennsylvania, Pennsylvania State University, Utrecht University, University Medical Center Utrecht, Duquesne University, University of Pittsburgh, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Long-Term Effects of COVID-19

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4296929463

FWCI: 0.573

Cites: 48

Cited by: 5

Related to: 10